NEW YORK (GenomeWeb News) – Boston-based investment advisor Wellington Management Company owns an 11.53 percent stake in Celera, according to a US Securities and Exchange Commission filing today.
According to the 13G/A filing, Wellington, in its capacity as an investment advisor, owns 9,094,951 shares on behalf of clients of the firm. It noted in the filing that “no such client is known to have such right of power with respect to more than five percent” of Celera’s common stock.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.